LBP1 Interim results of an open-label, multicentre, Phase 1/2 study to assess YTB323 (rapcabtagene autoleucel), a CAR T-cell therapy, for severe refractory systemic lupus erythematosus

Autor: Giulio Cavalli, Julia Weinmann-Menke, Clive Drakeford, Mi Kwon, Peter Gergely, Tamas Shisha, Pere Barba, Eva Wagner-Drouet, Josefina Cortés Hernández, José María Álvaro-Gracia Álvaro, Ozana Fischer, Beata Kovacs, Frédérique Chaperon, David Pearson, Tiina Kirsilä, Chih-Yung Sean Lee

Publikováno v: Lupus Science and Medicine, Vol 11, Iss Suppl 1 (2024)

Externí odkaz: https://doaj.org/article/969ef97739404cc7a904da14c37c2bcd

Tesidolumab (LFG316) for treatment of C5-variant patients with paroxysmal nocturnal hemoglobinuria

Autor: Jun-ichi Nishimura, Kiyoshi Ando, Masayoshi Masuko, Hideyoshi Noji, Yoshikazu Ito, Jiri Mayer, Laimonas Griskevicius, Christoph Bucher, Florian Müllershausen, Peter Gergely, Izabela Rozenberg, Anna Schubart, Raghav Chawla, Jean-Michel Rondeau, Michael Roguska, Igor Splawski, Mark T. Keating, Leslie Johnson, Rambabu Danekula, Morten Bagger, Yoko Watanabe, Börje Haraldsson, Yuzuru Kanakura

Publikováno v: Haematologica, Vol 107, Iss 6 (2022)

Externí odkaz: https://doaj.org/article/c663a2a787414f439fa282c457416a6b

Unwanted taxpayers

Autor: Peter Gergely Paszti

Publikováno v: Archives of Business Research. 9:207-214

While a relatively large amount of research is being conducted in prisons around the world, the number of searches allowed in penitentiary institutions in Hungary is very low. The problem is not only with the number of researches allowed, but also th

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::76ab30dbb795c784f9ae1269d06021b1
https://doi.org/10.14738/abr.912.11467

Preclinical characterization of the Toll-like receptor 7/8 antagonist MHV370 for lupus therapy

Autor: Stuart Hawtin, Cédric André, Géraldine Collignon-Zipfel, Simone Appenzeller, Bettina Bannert, Lea Baumgartner, Damian Beck, Claudia Betschart, Thomas Boulay, Hermine I. Brunner, Melanie Ceci, Jonathan Deane, Roland Feifel, Enrico Ferrero, Diego Kyburz, Frederique Lafossas, Pius Loetscher, Christina Merz-Stoeckle, Pierre Michellys, Barbara Nuesslein-Hildesheim, Friedrich Raulf, James S. Rush, Giulia Ruzzante, Thomas Stein, Samantha Zaharevitz, Grazyna Wieczorek, Richard Siegel, Peter Gergely, Tamas Shisha, Tobias Junt

Publikováno v: Cell Reports Medicine. 4:101036

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::951c34b5b48eafcb29d9636e9e49f20e
https://doi.org/10.1016/j.xcrm.2023.101036

Development and preliminary validation of the Sjögren’s Tool for Assessing Response (STAR): a consensual composite score for assessing treatment effect in primary Sjögren’s syndrome

Autor: Raphaele, Seror, Gabriel, Baron, Marine, Camus, Divi, Cornec, Elodie, Perrodeau, Simon J, Bowman, Michele, Bombardieri, Hendrika, Bootsma, Jacques-Eric, Gottenberg, Benjamin, Fisher, Wolfgang, Hueber, Joel A, van Roon, Valérie, Devauchelle-Pensec, Peter, Gergely, Xavier, Mariette, Raphael, Porcher, Marie, Wahren-Herlenius

Publikováno v: Annals of the Rheumatic Diseases, 81(7). BMJ PUBLISHING GROUP
Annals of the Rheumatic Diseases, 81, 189-190. BMJ PUBLISHING GROUP
Annals of the Rheumatic Diseases
Annals of the Rheumatic Diseases, 2022, pp.annrheumdis-2021-222054. ⟨10.1136/annrheumdis-2021-222054⟩
Annals of the Rheumatic Diseases, 2022, 81 (7), pp.979-989. ⟨10.1136/annrheumdis-2021-222054⟩

ObjectiveTo develop a composite responder index in primary Sjögren’s syndrome (pSS): the Sjögren’s Tool for Assessing Response (STAR).MethodsTo develop STAR, the NECESSITY (New clinical endpoints in primary Sjögren’s syndrome: an interventio

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e7c6311d86e6cf71758c555a5d4e7912
https://www.hal.inserm.fr/inserm-04030841